1. The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models. (October 2022) Authors: Joe, R.; Matsumura, Y.; Siddiqui, A.; Foulks, J.; Beg, M.; Thompson, J.; Yamamoto, N.; Spira, A.; Sarantopoulos, J.; Melear, J.; Lou, Y.; Lebedinsky, C.; Li, J.; Watanabe, A.; Warner, S. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pivotal topline data from the phase 1/2 TRIDENT-1 trial of repotrectinib in patients with ROS1+ advanced non-small cell lung cancer (NSCLC). (October 2022) Authors: Cho, B.C.; Lin, J.; Camidge, D.R.; Velcheti, V.; Solomon, B.; Lu, S.; Lee, K.H.; Kim, S.W.; Kao, S.; Diadziuskzko, R.; Beg, M.; Nagasaka, M.; Felip, E.; Besse, B.; Springfeld, C.; Popat, S.; Wolf, J.; Trone, D.; Stopatschinskaja, S.; Drilon, A. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cryptanalysis and Improvement of an Image Encryption Scheme Using Fourier Series. Issue 4 (December 2017) Authors: Ahmad, Musheer; Doja, M.; Beg, M. Journal: 3D research Issue: Volume 8:Issue 4(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cytokines, endothelial activation and microvascular dysfunction in acute respiratory syndrome due to Plasmodium vivax. (August 2018) Authors: Ghanchi, N.; Raza, A.; Beg, M.; Zubairi, A. Journal: International journal of infectious diseases Issue: Volume 73(2018)Supplement Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗